Please login to the form below

Not currently logged in
Email:
Password:

Video interview with Baroness Julia Neuberger

Baroness Julia Neuberger, winner of the 2010 Communiqué Award for Healthcare Communications Advocate, talks to John Clare about her key achievements and gives her view on current hot topics including NHS Reform

The Communiqué Awards, which recognise best practice in healthcare communications, took place in July this year. As she had been unable to attend to collect her prize for Healthcare Communications Advocate in person, John Clare CEO of LionsDen Communications caught up with Baroness Julia Neuberger. 

In this video interview, Baroness Neuberger talks about the key achievements in her career to date, which includes the 'Enhancing the healing environment' programme for which she was responsible during her time as chief executive of the King's Fund. 

Baroness Neuberger goes on to talk to John about what she would change if she were secretary of state for health and speaks frankly about her views on pharmaceutical companies involvement in medical education.

 


The full interview will be published in the December issue of Pharmaceutical Marketing magazine and includes Baroness Neuberger's views on pharmaceutical companies and their partnerships with the NHS, her opinion on clinical trial processes and her views on NHS Reform.


The interviewer
John Clare is CEO of LionsDen Communications
To comment on this article email webeditor@pmlive.com  

10th November 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...

Infographics